Advertisement
Screener

LEXICON PHARMACEUTICALS, INC. (LXRX) Cash Flow Breakdown

2.8 / 5 stars · 68/120 Roast Me

LEXICON PHARMACEUTICALS, INC. Cash Flow Breakdown

Cash flow breakdown shows where LEXICON PHARMACEUTICALS, INC.'s cash came from and where it went: from running the business, from investing (buying or selling equipment, companies and investments) and from financing (borrowing, paying back loans, buying back shares, paying dividends). One row per year or quarter. A minus sign means cash went out. Financing is shown line by line: buybacks, dividends, debt paid back, new debt and the rest. All amounts are the filed figures for that period.

  • Fiscal year ended 2025-12-31: from running the business, $67.85M went out.
  • Fiscal year ended 2025-12-31: from investing, $113.02M came in.
  • Fiscal year ended 2025-12-31: from financing, $48.50M went out.
  • Fiscal year ended 2025-12-31: change in cash, $3.33M went out.

A minus sign means cash went out. * = worked out from the filed year-to-date figures (hover to see how); greyed = already counted inside another line.

Each year (12 month)

Fiscal year endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2025-12-31-$67.85M$113.02M-$48.00M$0.00-$572.00K$0.00$0.00-$3.33M
2024-12-31-$178.78M-$15.38M$0.00$0.00-$1.73M$0.00-$1.31M$241.39M*$44.19M
2023-12-31-$161.90M-$49.94M$0.00$49.96M-$824.00K$138.82M$0.00-$23.88M
2022-12-31-$88.85M-$71.08M-$864.00K$48.87M$94.20M$0.00-$17.72M
2021-12-31-$87.02M$2.11M-$2.67M-$11.70M$37.08M-$62.20M
2020-12-31-$142.97M$380.76M-$1.03M-$216.58M$0.00$69.97M$90.15M
2019-12-31$113.81M-$155.85M-$941.00K-$1.28M$0.00$0.00-$44.27M
2018-12-31-$148.61M$169.58M-$972.00K-$14.53M$12.53M$732.00K$18.73M
2017-12-31-$185.39M$50.52M-$1.68M-$2.28M$145.91M$7.99M$0.00$15.06M
2016-12-31-$175.63M$18.25M-$621.00K-$2.02M$0.00$3.62M$0.00-$156.39M
2015-12-31$184.78M-$117.02M-$357.00K-$1.86M$0.00$114.00K$70.00K$65.72M
2014-12-31-$75.62M-$108.42M-$887.00K-$1.71M$84.14M$202.27M$0.00$99.77M
2013-12-31-$91.08M$99.54M-$873.00K-$1.57M$0.00$1.08M-$26.00K$7.08M
2012-12-31-$94.46M-$97.81M-$285.00K-$1.44M$0.00$38.11M$0.00-$155.89M
2011-12-31-$87.94M$69.95M-$108.00K-$3.59M$0.00$160.78M$0.00$139.10M
2010-12-31-$82.37M-$113.84M-$149.00K-$49.86M$11.38M$181.50M-$53.35M
2009-12-31-$89.02M$11.88M-$88.00K-$2.12M$38.59M$55.44M$14.68M

Each quarter (3 month)

Quarter endRunning the businessFrom investingBuybacksDebt paid backNew debtStaff share taxNew shares soldOtherNot split outChange in cash
2026-06-30-$9.19M*-$16.46M*-$54.26M*$0.00*$791.00K*$52.96M*
2026-03-31-$14.73M-$70.26M-$5.00M-$2.84M$69.99M$26.61M*$3.76M
2025-12-31-$17.23M*$4.83M*-$3.00M*$0.00*$0.00*
2025-09-30-$23.83M*$52.13M*$0.00*$0.00*$0.00*
2025-06-30$16.99M*$15.48M*-$45.00M*$0.00*$0.00*$0.00*
2025-03-31-$43.78M$40.58M$0.00-$572.00K$0.00$0.00-$3.77M
2024-12-31-$21.49M*$53.70M*$0.00*$0.00*$0.00*$0.00*$0.00*-$1.00K*
2024-09-30-$53.62M*$53.47M*$0.00*$0.00*$0.00*$0.00*$0.00*-$906.00K*
2024-06-30-$48.54M*-$12.32M*$0.00*$0.00*-$88.00K*$0.00*
2024-03-31-$55.13M-$110.22M-$1.73M-$400.00K$241.51M*$74.03M
2023-12-31-$50.55M*$51.90M*$0.00*-$1.00K*$0.00*$0.00*
2023-09-30-$41.62M*-$39.33M*$0.00*$1.00K*-$211.00K*$0.00*
2023-06-30-$38.12M*-$74.61M*$0.00*$49.96M*$139.03M*$0.00*
2023-03-31-$31.61M$12.09M-$824.00K$0.00$0.00$0.00-$20.34M
2022-12-31-$21.57M*$24.17M*$0.00*$24.97M*-$63.00K*
2022-09-30-$19.44M*-$77.20M*$0.00*-$249.00K*$94.27M*
2022-06-30-$24.42M*-$13.65M*$0.00*$0.00*$0.00*
2022-03-31-$23.42M-$4.41M-$864.00K$24.15M$0.00-$4.54M
2021-12-31-$22.83M*$6.10M*$0.00*-$11.70M*$379.00K*-$28.05M*
2021-09-30-$17.15M*-$400.00K*$0.00*$0.00*$0.00*$19.78M*$2.23M*
2021-06-30-$21.88M*$14.14M*$0.00*$0.00*$0.00*-$23.00K*-$7.76M*
2021-03-31-$25.16M-$17.72M-$2.67M$0.00$0.00$16.95M-$28.61M
2020-12-31-$34.24M*$44.10M*$0.00*-$5.82M*$69.97M*$74.01M*
2020-09-30-$40.38M*$215.80M*$0.00*-$210.12M*$0.00*-$34.69M*
2020-06-30-$46.30M*$78.07M*-$103.00K*-$322.00K*$0.00*$31.35M*
2020-03-31-$22.05M$42.78M-$923.00K-$321.00K$0.00$19.48M
2019-12-31-$24.37M*-$109.40M*$0.00*-$322.00K*$0.00*$0.00*-$134.09M*
2019-09-30$190.70M*-$31.28M*$0.00*-$320.00K*$0.00*$159.10M*
2019-06-30-$26.90M*-$7.45M*$0.00*-$322.00K*$0.00*-$34.67M*
2019-03-31-$25.62M-$7.73M-$941.00K-$321.00K$0.00-$34.61M
2018-12-31-$27.13M*$58.75M*$0.00*-$321.00K*$0.00*$182.00K*$31.48M*
2018-09-30-$22.18M*$56.40M*$0.00*-$13.04M*$158.00K*$12.53M*$33.86M*
2018-06-30-$52.52M*$47.37M*$0.00*-$588.00K*$367.00K*-$5.38M*
2018-03-31-$46.77M$7.06M-$972.00K-$581.00K$25.00K-$41.24M
2017-12-31-$33.71M*-$135.77M*$0.00*-$566.00K*$145.91M*$2.51M*-$21.63M*
2017-09-30-$33.96M*$87.05M*$0.00*-$552.00K*$54.00K*$52.59M*
2017-06-30-$32.23M*$56.79M*$0.00*-$626.00K*$4.32M*$28.25M*
2017-03-31-$85.50M$42.45M-$1.68M-$536.00K$1.11M-$44.15M
2016-12-31-$48.79M*$56.46M*$0.00*-$521.00K*$681.00K*$0.00*$7.83M*
2016-09-30-$35.22M*$33.90M*$0.00*-$507.00K*$2.19M*$0.00*$362.00K*
2016-06-30-$47.88M*$61.54M*$0.00*-$497.00K*$568.00K*$0.00*$13.73M*
2016-03-31-$43.74M-$133.64M-$621.00K-$491.00K$184.00K$0.00-$178.31M
2015-12-31$265.92M*-$124.14M*$0.00*-$480.00K*$0.00*$9.00K*$141.31M*
2015-09-30-$25.48M*$77.77M*$0.00*-$467.00K*$114.00K*$0.00*$51.93M*
2015-06-30-$32.18M*$340.00K*$0.00*-$456.00K*$0.00*$78.00K*-$32.22M*
2015-03-31-$23.48M-$70.99M-$357.00K-$456.00K$0.00-$17.00K-$95.31M
2014-12-31-$4.46M*-$170.72M*$0.00*-$442.00K*$201.94M*$27.00K*$84.14M*$110.49M*
2014-09-30-$21.19M*$20.51M*$0.00*-$429.00K*$163.00K*$0.00*-$950.00K*
2014-06-30-$19.66M*$1.22M*$0.00*-$419.00K*$86.00K*-$27.00K*-$18.79M*
2014-03-31-$30.32M$40.57M-$887.00K-$420.00K$76.00K$0.00$9.02M
2013-12-31-$21.74M*$39.77M*$0.00*-$407.00K*$210.00K*$85.00K*$17.92M*
2013-09-30-$23.93M*$20.24M*$0.00*-$394.00K*$527.00K*-$111.00K*-$3.67M*
2013-06-30-$21.13M*$10.43M*$0.00*-$386.00K*$98.00K*$0.00*-$10.99M*
2013-03-31-$24.27M$29.11M-$873.00K-$387.00K$249.00K$0.00$3.83M
2012-12-31-$20.43M*-$6.73M*$0.00*-$375.00K*$37.05M*$146.00K*$9.66M*
2012-09-30-$25.07M*$11.64M*$0.00*-$362.00K*$779.00K*-$10.00K*-$13.02M*
2012-06-30-$21.96M*$26.86M*$0.00*-$353.00K*$224.00K*$0.00*$4.77M*
2012-03-31-$27.00M-$129.57M-$285.00K-$353.00K$52.00K-$136.00K-$157.30M
2011-12-31-$22.49M*$18.03M*$0.00*-$345.00K*$0.00*$160.59M*$0.00*$155.79M*
2011-09-30-$20.22M*$30.74M*$0.00*-$329.00K*$0.00*$1.00K*$0.00*$10.19M*
2011-06-30-$23.69M*$26.50M*$0.00*-$2.63M*$28.00K*$0.00*$210.00K*
2011-03-31-$21.54M-$5.32M-$108.00K-$284.00K$160.00K$0.00-$27.09M
2010-12-31-$19.41M*-$145.10M*$0.00*-$271.00K*$0.00*$5.00K*-$164.78M*
2010-09-30-$18.63M*-$810.00K*$0.00*-$16.27M*$0.00*$0.00*-$35.71M*

Similar stocks

Stock NameCountryMarket CapPE Ratio
GYRE THERAPEUTICS, INC. (GYRE)United States$0.818B-24.71
Obsidian Therapeutics, Inc. (OBX)United States$0.829B
Immix Biopharma, Inc. (IMMX)United States$0.837B-18.44
Avalo Therapeutics, Inc. (AVTX)United States$0.842B-9.74
GERON CORP (GERN)United States$0.803B-12.14
Aclaris Therapeutics, Inc. (ACRS)United States$0.792B-9.78
Olema Pharmaceuticals, Inc. (OLMA)United States$0.790B-5.35
ARDELYX, INC. (ARDX)United States$0.857B-22.86
Wave Life Sciences, Inc. (WVE)$0.780B-5.56
Design Therapeutics, Inc. (DSGN)United States$0.766B-12.78